Zika virus: a new threat to the safety of the blood supply with worldwide impact and implications

Transfusion

Volumn 56, Issue 7, 2016, Pages 1907-1914

  Lanteri, Marion C ^a,b   Kleinman, Steven H ^c   Glynn, Simone A ^d   Musso, Didier ^e   Keith Hoots, W ^d   Custer, Brian S ^a,b   Sabino, Ester C ^f   Busch, Michael P ^a,b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e INSTITUT LOUIS MALARDÉ   (French Polynesia)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

AEDES; BLOOD; BLOOD DONOR; CHIKUNGUNYA VIRUS; DENGUE VIRUS; DISEASE ASSOCIATION; EPIDEMIC; EVIDENCE BASED PRACTICE; HEALTH CARE DELIVERY; HUMAN; INCIDENCE; MICROCEPHALY; NOTE; PATHOGENESIS; PUBLIC HEALTH PROBLEM; SEROLOGY; VIREMIA; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION; WESTERN HEMISPHERE; WORLD HEALTH ORGANIZATION; ZIKA FEVER; ZIKA VIRUS;

EID: 84977669021     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13677     Document Type: Note

References (85)

1. Atreya C, Nakhasi H, Mied P, et al. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion 2011;51:1855-71.
2. Glynn SA, Busch MP, Dodd RY, et al. Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century. Transfusion 2013;53:438-54.
3. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49 Suppl 2:1S-29S.
4. Fauci AS, Morens DM. Zika Virus in the Americas—yet another arbovirus threat. N Engl J Med 2016;374:601-4.
5. Lucey DR, Gostin LO. The emerging Zika pandemic: enhancing preparedness. JAMA 2016;315:865-6.
6. Petersen LR, Jamieson DJ, Powers AM, et al. Zika virus. N Engl J Med 2016;374:1552-63.
7. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003;349:1205-6.
8. Marks PW, Epstein JS, Borio L. Maintaining a safe blood supply in an era of emerging pathogens. J Infect Dis 2016;213:1676–7.
9. Kashima S, Slavov SN, Covas DT. Zika virus and its implication in transfusion safety. Rev Bras Hematol Hemoter 2016;38:90-1.
10. Busch MP. Infectious risks of blood transfusions: recent advances in testing technologies and new approaches to surveillance and decision-making. ISBT Sci Ser 2014;9:276-80.
11. Dodd RY. Getting to know the unknown. Transfusion 2014;54:1693-4.
12. Stein J, Besley J, Brook C, et al. Risk-based decision-making for blood safety: preliminary report of a consensus conference. Vox Sang 2011;101:277-81.
13. Gubler DJ, Kuno, G, Markoff, L. Flaviviruses fields virology. Philadelphia: Lippincott Williams & Wilkins; 2006.
14. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952;46:509-20.
15. Simpson DI. Zika virus infection in man. Trans R Soc Trop Med Hyg 1964;58:335-8.
16. Smithburn KC. Neutralizing antibodies against certain recently isolated viruses in the sera of human beings residing in East Africa. J Immunol 1952;69:223-34.
17. Macnamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954;48:139-45.
18. Haddow AJ, Williams MC, Woodall JP, et al. Twelve isolations of Zika virus from Aedes (Stegomyia) Africanus (Theobald) taken in and above a Uganda forest. Bull World Health Organ 1964;31:57-69.
19. Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev 2016;29:487-524.
20. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360:2536-43.
21. Mallet HP, Vial AL, Musso D. Bilan de l'épidémie à virus Zika en Polynésie française, 2013-2014. French Polynesia outbreak of Zika in French Polynesia, 2013-2014. Bulletin d'Information Sanitaires, Epidémiologiques et Statistiques; 2015.
22. Kelser EA. Meet dengue's cousin, Zika. Microbes Infect 2016;18:163-6.
23. Faye O, Freire CC, Iamarino A, et al. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis 2014;8:e2636
24. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232-9.
25. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014;20:O595-6.
26. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531-9.
27. Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia, December 2013. Euro Surveill 2014;19:20720.
28. Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015;21:1885-6.
29. Zanluca C, de Melo VC, Mosimann AL, et al. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 2015;110:569-72.
30. Musso D. Zika virus transmission from French Polynesia to Brazil. Emerg Infect Dis 2015;21:1887
31. Salvador FS, Fujita DM. Entry routes for Zika virus in Brazil after 2014 World Cup: new possibilities. Travel Med Infect Dis 2016;14:49-51.
32. Baronti C, Piorkowski G, Charrel RN, et al. Complete coding sequence of zika virus from a French Polynesia outbreak in 2013. Genome Announc 2014;2:e00500-14.
33. Cao-Lormeau VM, Musso D. Emerging arboviruses in the Pacific. Lancet 2014;384:1571-2.
34. Cao-Lormeau VM, Roche C, Teissier A, et al. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 2014;20:1085-6.
35. Hancock WT, Marfel M, Bel M. Zika virus, French Polynesia, South Pacific, 2013. Emerg Infect Dis 2014;20:1960
36. Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barre Syndrome. Stockholm: European Center for Disease and Control; 2015.
37. Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med 2016;374:951-8.
38. Costa F, Sarno M, Khouri R, et al. Emergence of congenital Zika syndrome: viewpoint from the front lines. Ann Intern Med 2016;164:689–91.
39. Sarno M, Sacramento GA, Khouri R, et al. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl Trop Dis 2016;10:e0004517.
40. Heymann DL, Hodgson A, Sall AA, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet 2016;387:719-21.
41. Fleming-Dutra KE, Nelson JM, Fischer M, et al. Update: interim guidelines for health care providers caring for infants and children with possible Zika virus infection—United States, February 2016. MMWR Morb Mortal Wkly Rep 2016;65:182-7.
42. Oliveira Melo AS, Malinger G, Ximenes R, et al. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016;47:6-7.
43. Brasil P, Pereira JP Jr, Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med 2016 [Epub ahead of print].
44. Martines RB, Bhatnagar J, Keating MK, et al. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016;65:159-60.
45. Rasmussen SA, Jamieson DJ, Honein MA, et al. Zika virus and birth defects—reviewing the evidence for causality. N Engl J Med 2016;374:1981–7.
46. Zika virus situation reports [Internet]. Geneva: World Health Organization; 2016 [cited 2016 Apr 1]. Available from: http://www.who.int/emergencies/zika-virus/situation-report/10-march-2016/en/.
47. Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 2016;387:2125–32.
48. Jouannic JM, Friszer S, Leparc-Goffart I, et al. Zika virus infection in French Polynesia. Lancet 2016;387:1051–2
49. Samarasekera U, Triunfol M. Concern over Zika virus grips the world. Lancet 2016;387:521-4.
50. Musso D, Baud D. Zika virus: time to move from case reports to case control. Lancet Infect Dis 2016;16:620–1.
51. Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016;374:2142–51.
52. Kindhauser MK, Allen T, Frank V, et al. Zika: the origin and spread of a mosquito-borne virus. Bull World Health Organ 2016 Feb 9 [Epub ahead of print]. DOI: http://dx.doi.org/10.2471/BLT.16.171082
53. Ayres CF. Identification of Zika virus vectors and implications for control. Lancet Infect Dis 2016;16:278-9.
54. Musso D, Cao-Lormeau VM, Gubler DJ. Zika virus: following the path of dengue and chikungunya? Lancet 2015;386:243-4.
55. Moreno-Sanchez R, Hayden M, Janes C, et al. A web-based multimedia spatial information system to document Aedes aegypti breeding sites and dengue fever risk along the US-Mexico border. Health Place 2006;12:715-27.
56. Haddow AD, Schuh AJ, Yasuda CY, et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis 2012;6:e1477
57. Ledermann JP, Guillaumot L, Yug L, et al. Aedes hensilli as a potential vector of Chikungunya and Zika viruses. PLoS Negl Trop Dis 2014;8:e3188
58. Stramer SL, Linnen JM, Carrick JM, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012;52:1657-66.
59. Besnard M, Lastere S, Teissier A, et al. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014;19. pii: 20751.
60. Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011;17:880-2.
61. Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015;21:359-61.
62. Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014;19. pii: 20761.
63. Gourinat AC, O'Connor O, Calvez E, et al. Detection of Zika virus in urine. Emerg Infect Dis 2015;21:84-6.
64. Musso D, Roche C, Nhan TX, et al. Detection of Zika virus in saliva. J Clin Virol 2015;68:53-5.
65. Atkinson BH, Afrough B, Lumley S, et al. Detection of Zika virus in semen. Emerg Infect Dis 2016;22:940.
66. Nett RJ, Kuehnert MJ, Ison MG, et al. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis 2012;14:268-77.
67. Tan FL, Loh DL, Prabhakaran K, et al. Dengue haemorrhagic fever after living donor renal transplantation. Nephrol Dial Transplant 2005;20:447-8.
68. Waggoner JJ, Pinsky BA. Zika virus: diagnostics for an emerging pandemic threat. J Clin Microbiol 2016;54:860-7.
69. Musso D, Aubry M, Broult JA, et al. Zika virus: new emergencies, potential for severe complications, and prevention of transfusion-transmitted Zika fever in the context of arboviruses co-circulation. Blood Transfus 2016; doi: 10.2450/2016.0003-16.
70. Marano G, Pupella S, Vaglio S, et al. Zika virus and the never-ending story of emerging pathogens and transfusion medicine. Blood Transfus 2016;14:95-100.
71. Aubry M, Finke J, Teissier A, et al. Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis 2015;41:11-2.
72. Franchini M, Velati C. Blood safety and zoonotic emerging pathogens: now it's the turn of Zika virus! Blood Transfus 2016;14:93-4.
73. Zammarchi L, Stella G, Mantella A, et al. Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J Clin Virol 2015;63:32-5.
74. Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus: guidance for industry. Silver Spring (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2016.
75. Association Bulletin #16-03 Re: Zika, Dengue, and Chikungunya Viruses. Bethesda (MD): AABB; 2016.
76. Association Bulletin #16-04 Re: Zika, Dengue, and Chikungunya Viruses. Bethesda (MD): AABB; 2016.
77. AFP. WHO sounds Zika blood warning as Europe sees first pregnancy case [Internet]. Geneva: World Health Organization; 2016 [cited 2016 May 30]. Available from: https://www.yahoo.com/news/advises-against-blood-donations-people-returning-zika-areas-180951415.html?ref=gs.
78. Zika virus disease epidemic Safety of substances of human origin. Solna: European Centre for Disease Prevention and Control (ECDC); 2016.
79. Brown C. Zika virus outbreaks in Asia and South America. CMAJ 2016;188:E34.
80. Calvet GA, Filippis AM, Mendonca MC, et al. First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil. J Clin Virol 2015;74:1-3.
81. Gatherer D, Kohl A. Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol 2016;97:269-73.
82. Aubry M, Richard V, Green J, et al. Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination. Transfusion 2016;56:33-40.
83. Maintaining a safe and adequate blood supply during Zika virus outbreaks: interim guidance. Geneva: World Health Organization; 2016.
84. Sabino EC, Loureiro P, Lopes ME, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis 2016;213:694–702.
85. Heymann DL, Liu J, Lillywhite L. Partnerships, not parachutists, for Zika research. N Engl J Med 2016;374:1504–5.